The stock's rise snapped a three-day losing streak.

ResMed (NYSE:RMD) has had a rough month with its share price down 7.5%. However, stock prices are usually driven by ...

New insights from 30,026 people across 13 markets show the global scale of poor sleep and its impact on health, work, and relationships7 out of 10 employed respondents have called in sick at least onc ...

Shares of ResMed Inc. RMD slipped 1.03% to $230.58 Tuesday, on what proved to be an all-around great trading session for the ...

Principal Financial Group Inc. trimmed its stake in ResMed Inc. (NYSE:RMD – Free Report) by 0.5% during the 4th quarter, Holdings Channel reports. The firm owned 185,788 shares of the medical ...

Equities researchers at Zacks Research raised their Q3 2025 earnings per share estimates for ResMed in a report issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates ...

The global ventilator market, valued at US$3.86 billion in 2023, is forecasted to grow at a robust CAGR of 4.7%, reaching US$3.71 billion in ...

Brett Fishbin; Analyst; KeyBanc Capital Markets Inc. Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator ...

The global ventilator market, valued at US$3.86 billion in 2023, is forecasted to grow at a robust CAGR of 4.7%, reaching ...

Welcome to the Q2 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Matt, and I'll be your operator for today's call. At this time, all participants are in a listen-only mode.

ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth opportunities in the sleep apnea market.